{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:04:29Z","timestamp":1791353069295,"version":"4.3.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2389,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.immuni.2006.11.010","type":"journal-article","created":{"date-parts":[[2007,1,19]],"date-time":"2007-01-19T07:19:16Z","timestamp":1169191156000},"page":"67-78","source":"Crossref","is-referenced-by-count":140,"title":["Fc\u03b3RIII-Dependent Inhibition of Interferon-\u03b3 Responses Mediates Suppressive Effects of Intravenous Immune Globulin"],"prefix":"10.1016","volume":"26","author":[{"given":"Kyung-Hyun","family":"Park-Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya V.","family":"Serbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Krystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin G.","family":"Neel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel B.","family":"Ivashkiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2006.11.010_bib1","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.4049\/jimmunol.174.9.5837","article-title":"Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease","volume":"174","author":"Abe","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2006.11.010_bib2","first-page":"1328","article-title":"The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease","volume":"113","author":"Akilesh","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.immuni.2006.11.010_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.0105-2896.2005.00252.x","article-title":"Interferons as pathogenic effectors in autoimmunity","volume":"204","author":"Baccala","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2006.11.010_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.186.3.385","article-title":"Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice","volume":"186","author":"Balasa","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2006.11.010_bib5","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1172\/JCI117520","article-title":"High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments","volume":"94","author":"Basta","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.immuni.2006.11.010_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nm836","article-title":"F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins","volume":"9","author":"Basta","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2006.11.010_bib7","first-page":"6","article-title":"Regulation of interferon-gamma receptor (INF-gammaR) chains: a peculiar way to rule the life and death of human lymphocytes","volume":"12","author":"Bernabei","year":"2001","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.immuni.2006.11.010_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00002281-200305000-00010","article-title":"Immunoglobulin for rheumatic diseases in the twenty-first century: take it or leave it?","volume":"15","author":"Braun-Moscovici","year":"2003","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.immuni.2006.11.010_bib9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(03)00080-3","article-title":"Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease","volume":"18","author":"Bruhns","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2006.11.010_bib10","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood-2005-03-1196","article-title":"The ETS factor TEL2 is a hematopoietic oncoprotein","volume":"107","author":"Carella","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2006.11.010_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI23994","article-title":"Immune complexes as therapy for autoimmunity","volume":"115","author":"Clynes","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2006.11.010_bib12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2003-01-0023","article-title":"IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity","volume":"102","author":"Crow","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2006.11.010_bib13","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.1073\/pnas.0408854102","article-title":"Inhibition of IFN-alpha signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway","volume":"102","author":"Du","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2006.11.010_bib14","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.4049\/jimmunol.131.5.2117","article-title":"Inhibition of macrophage tumoricidal activity by immune complexes and altered erythrocytes","volume":"131","author":"Esparza","year":"1983","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2006.11.010_bib15","doi-asserted-by":"crossref","first-page":"6861","DOI":"10.4049\/jimmunol.166.11.6861","article-title":"Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors","volume":"166","author":"Gerber","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2006.11.010_bib16","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/WNL.59.8.1170","article-title":"Molecular profiles of inflammatory myopathies","volume":"59","author":"Greenberg","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.immuni.2006.11.010_bib17","doi-asserted-by":"crossref","first-page":"re1","DOI":"10.1126\/stke.3202006re1","article-title":"Inhibition of immune responses by ITAM-bearing receptors","volume":"2006","author":"Hamerman","year":"2006","journal-title":"Sci. STKE"},{"key":"10.1016\/j.immuni.2006.11.010_bib18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ni1204","article-title":"Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12","volume":"6","author":"Hamerman","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2006.11.010_bib19","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1101\/gad.12.11.1610","article-title":"Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span","volume":"12","author":"Helgason","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.immuni.2006.11.010_bib20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/ni828","article-title":"Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation","volume":"3","author":"Hu","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2006.11.010_bib21","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1126\/science.8456301","article-title":"Immune response in mice that lack the interferon-gamma receptor","volume":"259","author":"Huang","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.immuni.2006.11.010_bib22","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/rheumatology\/keh488","article-title":"Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes\/macrophages during acute Kawasaki disease","volume":"44","author":"Ichiyama","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.immuni.2006.11.010_bib23","first-page":"81","article-title":"Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies","volume":"151","author":"Illa","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.immuni.2006.11.010_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/ar1197","article-title":"Signaling by STATs","volume":"6","author":"Ivashkiv","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.immuni.2006.11.010_bib25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ni0603-507","article-title":"Matching SOCS with function","volume":"4","author":"Johnston","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2006.11.010_bib26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2006.11.010_bib27","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1038\/sj.onc.1204756","article-title":"In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression","volume":"20","author":"Kihara-Negishi","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.immuni.2006.11.010_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000069447","article-title":"Autoantibody level modification in adult patients with idiopathic thrombocytopenic purpura following intravenous immunoglobulin treatment","volume":"16","author":"Levy","year":"1998","journal-title":"Nat. Immun."},{"key":"10.1016\/j.immuni.2006.11.010_bib29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20041470","article-title":"A role for IgG immune complexes during infection with the intracellular pathogen Leishmania","volume":"201","author":"Miles","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2006.11.010_bib30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.it.2004.08.008","article-title":"Signal regulators in FcR-mediated activation of leukocytes?","volume":"25","author":"Mina-Osorio","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2006.11.010_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.autrev.2004.11.010","article-title":"Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia","volume":"4","author":"Musaji","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.immuni.2006.11.010_bib32","doi-asserted-by":"crossref","first-page":"25762","DOI":"10.1074\/jbc.270.43.25762","article-title":"Ligand binding and phagocytosis by CD16 (Fc gamma receptor III) isoforms. Phagocytic signaling by associated zeta and gamma subunits in Chinese hamster ovary cells","volume":"270","author":"Nagarajan","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.immuni.2006.11.010_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2005.05.010","article-title":"FcgammaRIV: a novel FcR with distinct IgG subclass specificity","volume":"23","author":"Nimmerjahn","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2006.11.010_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-1119(02)01156-3","article-title":"Molecular biology of the Ets family of transcription factors","volume":"303","author":"Oikawa","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.immuni.2006.11.010_bib35","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nri1461","article-title":"Immune responses to Listeria monocytogenes","volume":"4","author":"Pamer","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2006.11.010_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1074-7613(04)00377-2","article-title":"Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM","volume":"22","author":"Pasquier","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2006.11.010_bib37","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.4049\/jimmunol.173.10.6211","article-title":"Differential gene expression modulated by the cytoplasmic domain of Fc gamma RIa (CD64) alpha-chain","volume":"173","author":"Qin","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2006.11.010_bib38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.19.1.275","article-title":"IgG Fc receptors","volume":"19","author":"Ravetch","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2006.11.010_bib39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.290.5489.84","article-title":"Immune inhibitory receptors","volume":"290","author":"Ravetch","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.immuni.2006.11.010_bib40","doi-asserted-by":"crossref","first-page":"28947","DOI":"10.1074\/jbc.271.46.28947","article-title":"The structure of the gene for the second chain of the human interferon-gamma receptor","volume":"271","author":"Rhee","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.immuni.2006.11.010_bib41","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor","volume":"291","author":"Samuelsson","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.immuni.2006.11.010_bib42","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/346844a0","article-title":"Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma","volume":"346","author":"Sarvetnick","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2006.11.010_bib43","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1074-7613(03)00330-3","article-title":"Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection","volume":"19","author":"Serbina","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2006.11.010_bib44","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1172\/JCI16577","article-title":"C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease","volume":"110","author":"Shushakova","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.immuni.2006.11.010_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI200522753","article-title":"Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?","volume":"115","author":"Siragam","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.immuni.2006.11.010_bib46","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nm1416","article-title":"Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells","volume":"12","author":"Siragam","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2006.11.010_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.immuni.2006.11.010_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1471-4906(03)00065-6","article-title":"Suppression of antiviral responses by antibody-dependent enhancement of macrophage infection","volume":"24","author":"Suhrbier","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2006.11.010_bib49","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood.V98.4.1095","article-title":"Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia","volume":"98","author":"Teeling","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2006.11.010_bib50","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4049\/jimmunol.133.1.104","article-title":"Suppression of the immune response to Listeria monocytogenes. I. Immune complexes inhibit resistance","volume":"133","author":"Virgin","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2006.11.010_bib51","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.4049\/jimmunol.135.6.3735","article-title":"Immune complex effects on murine macrophages. I. Immune complexes suppress interferon-gamma induction of Ia expression","volume":"135","author":"Virgin","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2006.11.010_bib52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev.immunol.18.1.143","article-title":"Negative regulation of cytokine signaling pathways","volume":"18","author":"Yasukawa","year":"2000","journal-title":"Annu. Rev. Immunol."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761306005668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761306005668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T08:58:15Z","timestamp":1683709095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761306005668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1074761306005668"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2006.11.010","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1061855.516649","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1061855.513799","asserted-by":"object"}]},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}